Stem cell production
Cellcolabs has raised €24M across 3 funding rounds from 14 investors, most recently a round in Oct 2025. Based in Solna, Sweden; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2025-10-27 | Other | €10M | Titian Capital | View deal → |
| 2024-03-05 | Other | €8.0M | Filip Engelbert,Fredrik Österberg,Jens von Bahr,Jonas Nordlander,Norrsken Launcher | View deal → |
| 2022-03-23 | Other | €6.2M | Fredrik Jung-Abbou,Ash Pournouri,Filip Engelbert,Fredrik Hjelm,Johannes Schildt,John Hedberg+4 more | View deal → |
